Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glutamine”

190 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 190 results

Early research (Phase 1)Ended earlyNCT03275974
What this trial is testing

Glutamine PET Imaging Colorectal Cancer

Who this might be right for
RAS Wild TypeStage IV Colorectal CancerStage IVA Colorectal Cancer+1 more
M.D. Anderson Cancer Center 6
Early research (Phase 1)Not Yet RecruitingNCT07430202
What this trial is testing

A DNAJB1-PRKACA Fusion Kinase Peptide Vaccine Combined With Glutamine Antagonist DRP-104, Nivolumab, and Ipilimumab in Patients With Advanced Stage Fibrolamellar Carcinoma (FLC)

Who this might be right for
Liver Cancer (Fibrolamellar Hepatocellular Cancer (FLC))
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 27
Large-scale testing (Phase 3)Ended earlyNCT00318331
What this trial is testing

Enteral Glutamine in Critical Illness

Who this might be right for
Critical IllnessSepsisRespiratory Insufficiency
Christiana Care Health Services 20
Not applicableStudy completedNCT05054517
What this trial is testing

Oral Glutamine and Thoracic/Upper Aerodigestive Tumors Radiation Toxicity

Who this might be right for
Biopsy Confirmed Head and Neck Cancer and Tumors of the Chest
National and Kapodistrian University of Athens 72
Testing effectiveness (Phase 2)Looking for participantsNCT07039747
What this trial is testing

Effectiveness of a Dietary Supplement in Irritable Bowel Syndrome

Who this might be right for
Irritable Bowel Syndrome
University Hospital, Rouen 100
Not applicableWithdrawnNCT00217035
What this trial is testing

Glutamine Enriched Total Parenteral Feeding and Proline Metabolism in Severely Burned Patients

Who this might be right for
Burns
Massachusetts General Hospital
Testing effectiveness (Phase 2)Study completedNCT00365768
What this trial is testing

Glutamine in Treating Neuropathy Caused by Vincristine in Young Patients With Lymphoma, Leukemia, or Solid Tumors

Who this might be right for
Kidney CancerLeukemiaLymphoma+3 more
Columbia University 56
Not applicableUnknownNCT00922688
What this trial is testing

Dipeptide Alanyl Glutamine and Postoperative Insulin Resistance in Colon Carcinoma Patients

Who this might be right for
Colon Carcinoma
Medical Center Alkmaar 30
Large-scale testing (Phase 3)UnknownNCT04710290
What this trial is testing

A Cohort Study of Beta-Glucan or Beta-Glucan Compound in Metastatic Cancers

Who this might be right for
Metastatic CancerChemotherapy
E-DA Hospital 90
Early research (Phase 1)Study completedNCT02071927
What this trial is testing

Study of the Glutaminase Inhibitor CB-839 in Leukemia

Who this might be right for
Acute Myeloid Leukemia (AML)Acute Lymphocytic Leukemia (ALL)
Calithera Biosciences, Inc 43
Large-scale testing (Phase 3)UnknownNCT02282839
What this trial is testing

Oral Glutamine and Mucositis of Head and Neck Cancer Patients Undergoing Radiation

Who this might be right for
Head and Neck CancerMucositis
Taichung Veterans General Hospital 60
Testing effectiveness (Phase 2)Study completedNCT03163667
What this trial is testing

CB-839 With Everolimus vs. Placebo With Everolimus in Participants With Renal Cell Carcinoma (RCC)

Who this might be right for
Clear Cell Renal Cell Carcinoma
Calithera Biosciences, Inc 69
Testing effectiveness (Phase 2)Ended earlyNCT01353638
What this trial is testing

Safety and Efficacy of the Addition of Alanyl-Glutamine-Dipeptide to Dialysis Solution in Peritoneal Dialysis

Who this might be right for
End Stage Renal Disease
Christoph Aufricht 25
Not applicableLooking for participantsNCT04883515
What this trial is testing

Effects of Oral Glutamine Supplementation on Insulin Resistance and Functional Intestinal Disorders in Obese Patients.

Who this might be right for
ObesityInsulin Resistance
University Hospital, Rouen 110
Early research (Phase 1)Study completedNCT04388371
What this trial is testing

Glutamine PET Imaging in LAM

Who this might be right for
Lymphangioleiomyomatosis (LAM)
Vanderbilt University Medical Center 5
Very early researchUnknownNCT05569993
What this trial is testing

Glutamine and Traumatic Brain Injury

Who this might be right for
Brain Injuries, Traumatic
Assiut University 60
Not applicableUnknownNCT03721055
What this trial is testing

Fluoroglutamine PET/CT in Imaging Patients With Malignant Tumor

Who this might be right for
CancerMetastatic CancerMetastatic Brain Cancer
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 60
Not applicableUnknownNCT03517254
What this trial is testing

Use of Glutamine for Recovery Muscle Strength

Who this might be right for
Anterior Cruciate Ligament Reconstruction
Instituto Nacional de Rehabilitacion 30
Early research (Phase 1)Study completedNCT02071888
What this trial is testing

Study of the Glutaminase Inhibitor CB-839 in Hematological Tumors

Who this might be right for
Non-Hodgkin's Lymphoma (NHL)Multiple MyelomaWaldenstrom's Macroglobulinemia (WM)+2 more
Calithera Biosciences, Inc 25
Testing effectiveness (Phase 2)Study completedNCT03428217
What this trial is testing

CANTATA: CB-839 With Cabozantinib vs. Cabozantinib With Placebo in Patients With Metastatic Renal Cell Carcinoma

Who this might be right for
Advanced Renal Cell CarcinomaMetastatic Renal Cell Carcinoma
Calithera Biosciences, Inc 444
Next Page